Archive \ Volume.3 2012 Issue 2

Study the clinical phamacist influence on medication adherence & quality of life of rural type- 2 diabetes mellitus patients in a tertiary care hospital

K.V. Ramanath , Bhanuprakash.M , Nagakishore.CH , Mahesh kumar.S , Balaji D.B.S.S , ...
Abstract

Objective: To assess the impact of clinical pharmacist involvement in the medication adherence of Diabetes mellitus patients. Methodology: A Prospective, Randomized and interventional study was carried out in the medicine department for a period of 8 months in Adichuchanagiri hospital and research centre, B.G.Nagar. The patients were grouped in to control and intervention after obtaining their consent. These patients’ data was collected by using a well designed patient data collection form. The questionnaires were used to know the medication adherence behaviour and quality of life. Significance is assessed at 5 % level of significance. Result: A total of 48 patients are enrolled in which 24 in control 24 in intervention groups. The Morisky medication adherence scale (MMAS) and medication adherence report scale (MARS) were showed P value 0.007**, <0.001**. The SF- 12 for quality of life (QOL) questionnaire showed P value 0.293 in physical component summary (PCS) and 0.001** in mental component summary (MCS) respectively. Conclusion: The present study concluded that continuous education programs/counselling is important for Diabetes mellitus patients to emphasize and re-emphasize on the disease management and this study also showed positive results in medication adherence behaviour and disease management (QOL).Objective: To assess the impact of clinical pharmacist involvement in the medication adherence of Diabetes mellitus patients. Methodology: A Prospective, Randomized and interventional study was carried out in the medicine department for a period of 8 months in Adichuchanagiri hospital and research centre, B.G.Nagar. The patients were grouped in to control and intervention after obtaining their consent. These patients’ data was collected by using a well designed patient data collection form. The questionnaires were used to know the medication adherence behaviour and quality of life. Significance is assessed at 5 % level of significance. Result: A total of 48 patients are enrolled in which 24 in control 24 in intervention groups. The Morisky medication adherence scale (MMAS) and medication adherence report scale (MARS) were showed P value 0.007**, <0.001**. The SF- 12 for quality of life (QOL) questionnaire showed P value 0.293 in physical component summary (PCS) and 0.001** in mental component summary (MCS) respectively. Conclusion: The present study concluded that continuous education programs/counselling is important for Diabetes mellitus patients to emphasize and re-emphasize on the disease management and this study also showed positive results in medication adherence behaviour and disease management (QOL).